Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

PubWeight™: 5.74‹?› | Rank: Top 1%

🔗 View Article (PMC 2987704)

Published in Lancet on March 17, 1984

Authors

T E Starzl, M A Nalesnik, K A Porter, M Ho, S Iwatsuki, B P Griffith, J T Rosenthal, T R Hakala, B W Shaw, R L Hardesty

Articles citing this

(truncated to the top 100)

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med (1992) 4.11

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. J Clin Oncol (2010) 2.69

Personal experience with 411 hepatic resections. Ann Surg (1988) 2.46

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med (1999) 2.27

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol (1997) 2.05

The post-transplant lymphoproliferative disorder-a literature review. Pediatr Nephrol (2004) 1.92

Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88

Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood (2006) 1.75

Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood (2005) 1.73

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72

Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol (1989) 1.65

Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis (1985) 1.62

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol (1993) 1.58

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56

AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol (1991) 1.45

Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J Virol (1988) 1.37

Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders. J Clin Microbiol (1999) 1.37

Potential selection of LMP1 variants in nasopharyngeal carcinoma. J Virol (2004) 1.34

Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Proc Natl Acad Sci U S A (1992) 1.28

Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. J Exp Med (1996) 1.27

Epstein-Barr virus infection and human malignancies. Int J Exp Pathol (2001) 1.24

High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol (2000) 1.24

Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis (1987) 1.24

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18

Transforming growth factor-beta and suppression of humoral immune responses in HIV infection. J Clin Invest (1991) 1.18

Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J Virol (1991) 1.18

Heart transplant pathology: the British experience. J Clin Pathol (1985) 1.17

Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg (2002) 1.16

A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg (1985) 1.15

Liver transplantation in the ciclosporin era. Prog Allergy (1986) 1.14

Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients. J Mol Diagn (2000) 1.06

Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci (1994) 1.06

Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★). Am J Transplant (2011) 1.04

Treating rheumatic patients with a malignancy. Arthritis Res Ther (2011) 1.03

Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc (1994) 1.03

Liver transplantation in the UK. World J Gastroenterol (2001) 1.02

Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry (1996) 1.01

Detection of Epstein-Barr virus DNA in mouthwashes by hybridization. J Clin Microbiol (1985) 0.99

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases. Haematologica (2011) 0.98

Themes of liver transplantation. Hepatology (2010) 0.98

Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. J Clin Invest (1987) 0.97

Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation (1999) 0.96

Late mortality and morbidity after liver transplantation. Transplant Proc (1987) 0.95

Cadaveric renal transplantation under the American organ allocation system. Contrib Nephrol (1989) 0.93

The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93

Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol (1990) 0.93

History of clinical transplantation. World J Surg (2000) 0.91

Cadaveric renal transplantation at the University of Pittsburgh: a two and one-half-year experience with the point system. Clin Transpl (1988) 0.90

Genotypic analyses of cyclosporine-associated lymphoproliferations. Transplantation (1987) 0.90

Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. Am J Pathol (1999) 0.89

Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep (2013) 0.89

Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol (1995) 0.88

Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer (2016) 0.88

Blood transfusion as a risk factor for non-Hodgkin lymphoma. Br J Cancer (1996) 0.87

Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders. Am J Pathol (1997) 0.86

Clonal characteristics of posttransplant lymphoproliferative disorders. Transplant Proc (1988) 0.86

Monitoring and managing viral infections in pediatric renal transplant recipients. Pediatr Nephrol (2011) 0.86

Viral and toxoplasma gondii infections in children after liver transplantation. J Clin Pathol (1990) 0.86

Herpesvirus infections in organ transplant recipients. Clin Diagn Lab Immunol (2003) 0.86

Lung Malignancies in HIV Infection. Semin Respir Crit Care Med (2016) 0.85

Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine. Am J Pathol (1987) 0.85

Induction of stable chimerism and elimination of graft-versus-host disease by depletion of T lymphocytes from bone marrow using immunomagnetic beads. Surgery (1989) 0.85

Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II. Dig Dis Sci (2008) 0.84

Monomorphic post-transplant lymphoproliferative disorder of the tongue: case report and review of literature. Diagn Pathol (2007) 0.84

Early tolerance in pediatric liver allograft recipients. J Pediatr Surg (1994) 0.84

Progress in liver transplantation. Adv Surg (1988) 0.83

The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients. Viruses (2010) 0.83

Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J Clin Invest (1992) 0.83

Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases. Environ Health Perspect (1990) 0.83

Predicting success or failure of immunotherapy for cancer: insights from a clinically applicable mathematical model. Am J Cancer Res (2012) 0.83

Posttransplant lymphoproliferative disease after pediatric solid organ transplantation. Clin Dev Immunol (2013) 0.83

Primary leiomyoma of the liver: a review of a rare tumour. HPB Surg (2014) 0.83

Smooth muscle tumor arising de novo in a liver allograft: A case report. Clin Transplant (1991) 0.82

EBV Persistence-Introducing the Virus. Curr Top Microbiol Immunol (2015) 0.82

Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle. PLoS Pathog (2014) 0.82

EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression--a case report. Diagn Pathol (2010) 0.82

Gastrointestinal complications after cardiac transplantation. Potential benefit of early diagnoses and prompt surgical intervention. Ann Surg (1990) 0.81

Pathogens in children with severe combined immune deficiency disease or AIDS. CMAJ (1986) 0.81

Lymphoproliferative disorders in Oxford renal transplant recipients. J Clin Pathol (2003) 0.81

Therapeutic options in post-transplant lymphoproliferative disorders. Ther Adv Hematol (2011) 0.81

Homogeneous immunoglobulins in the sera of lung carcinoma patients receiving cytotoxic chemotherapy--detection with the use of isoelectric focusing and immunoblotting. Clin Exp Immunol (1987) 0.80

Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment. Can J Infect Dis (2002) 0.80

Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease. Expert Rev Clin Immunol (2010) 0.80

De novo malignancy after paediatric renal replacement therapy. Arch Dis Child (2001) 0.80

Incidence and occupational pattern of leukaemias, lymphomas, and testicular tumours in western Ireland over an 11 year period. J Epidemiol Community Health (1998) 0.80

Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplant (1992) 0.80

Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens. Mol Pathol (2001) 0.80

Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders. Clin Transplant (1999) 0.80

Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010. Infect Agent Cancer (2014) 0.79

Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants. Am J Kidney Dis (1985) 0.78

Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy. Am J Pathol (2002) 0.78

Characterization of clonality of Epstein-Barr virus-induced human B lymphoproliferative disease in mice with severe combined immunodeficiency. Am J Pathol (1993) 0.78

Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes. Antimicrob Agents Chemother (1994) 0.78

Articles cited by this

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem (1981) 38.93

Evolution of liver transplantation. Hepatology (1982) 19.54

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer (1982) 3.65

Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg (1983) 3.15

Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92

Kaposi's sarcoma in recipients of renal transplants. Am J Med (1979) 2.45

Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med (1984) 1.78

Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: an initial report. J Surg Res (1978) 1.60

Ia antigen expression by human malignant lymphomas: correlation with conventional lymphoid markers. Blood (1980) 1.33

Reactive lymphoid hyperplasia with single class (monoclonal) surface immunoglobulin. Am J Clin Pathol (1983) 1.32

The price of immunotherapy. Curr Probl Surg (1981) 1.29

Immunosuppression and malignant neoplasms. N Engl J Med (1970) 1.18

Lymphomas and pseudolymphomas of the alimentary tract. An immunohistochemical study with clinicopathologic correlations. Hum Pathol (1981) 1.15

Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients. Cancer Res (1981) 1.11

Kaposi's sarcoma in a patient after renal transplantation. Postgrad Med J (1983) 1.06

Malignant lymphoma in a renal transplant recipient treated with antithymocyte globulin. Transplantation (1983) 1.00

Pseudolymphoma in renal allograft recipients. Arch Surg (1978) 1.00

Immunosuppression and malignant neoplasms. N Engl J Med (1970) 0.97

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut (2002) 3.73

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A (1970) 3.66

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54